These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia. Moga S, Bobosha K, Fikadu D, Zerihun B, Diriba G, Amare M, Kempker RR, Blumberg HM, Abebe T. PLoS One; 2023; 18(4):e0284737. PubMed ID: 37099514 [Abstract] [Full Text] [Related]
11. Analysis of drug resistance mutations in pulmonary Mycobacterium tuberculosis isolates in the Southern coastal region of Andhra Pradesh, India. Polu GP, Mohammad Shaik J, Kota NMK, Karumanchi D, Allam US. Braz J Infect Dis; 2019; 23(5):281-290. PubMed ID: 31421108 [Abstract] [Full Text] [Related]
14. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis. Kabir S, Junaid K, Rehman A. Int J Infect Dis; 2021 Feb; 103():56-61. PubMed ID: 33181327 [Abstract] [Full Text] [Related]
16. Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India. Singhal R, Arora J, Sah GC, Bhalla M, Sarin R, Prasad Myneedu V. J Epidemiol Glob Health; 2017 Sep; 7(3):175-180. PubMed ID: 28756826 [Abstract] [Full Text] [Related]
19. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. Meaza A, Kebede A, Yaregal Z, Dagne Z, Moga S, Yenew B, Diriba G, Molalign H, Tadesse M, Adisse D, Getahun M, Desta K. BMC Infect Dis; 2017 Apr 17; 17(1):280. PubMed ID: 28415989 [Abstract] [Full Text] [Related]